Sigma Healthcare 将来の成長

Future 基準チェック /66

Sigma Healthcare利益と収益がそれぞれ年間47.3%と21.5%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に61.6% 34.4%なると予測されています。

主要情報

47.3%

収益成長率

34.4%

EPS成長率

Healthcare 収益成長	27.5%
収益成長率	21.5%
将来の株主資本利益率	61.6%
アナリストカバレッジ	Low
最終更新日	10 Nov 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

DB:S5YA - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2027	8,900	725	585	1,018	2
6/30/2026	8,263	606	467	515	2
6/30/2025	5,384	270	625	-145	2
7/31/2024	3,481	-3	-69	-64	N/A
4/30/2024	3,401	1	-16	-11	N/A
1/31/2024	3,322	5	37	42	N/A
10/31/2023	3,414	10	29	39	N/A
7/31/2023	3,506	15	21	36	N/A
4/30/2023	3,583	8	64	86	N/A
1/31/2023	3,660	2	107	136	N/A
10/31/2022	3,605	-3	71	98	N/A
7/31/2022	3,550	-7	36	61	N/A
4/30/2022	3,498	-7	-12	7	N/A
1/31/2022	3,446	-7	-60	-46	N/A
10/31/2021	3,469	20	-51	-33	N/A
7/31/2021	3,491	47	-42	-20	N/A
4/30/2021	3,446	45	-53	-16	N/A
1/31/2021	3,400	44	-65	-13	N/A
10/31/2020	3,205	12	-21	37	N/A
7/31/2020	3,009	-19	23	87	N/A
4/30/2020	3,127	-16	84	145	N/A
1/31/2020	3,244	-12	146	203	N/A
10/31/2019	3,570	7	87	153	N/A
7/31/2019	3,897	26	28	104	N/A
4/30/2019	3,937	31	-36	56	N/A
1/31/2019	3,977	37	-100	8	N/A
10/31/2018	4,015	39	-53	46	N/A
7/31/2018	4,054	41	-7	84	N/A
4/30/2018	4,074	48	N/A	77	N/A
1/31/2018	4,094	55	N/A	71	N/A
10/31/2017	4,156	56	N/A	94	N/A
7/31/2017	4,218	57	N/A	117	N/A
4/30/2017	4,292	55	N/A	131	N/A
1/31/2017	4,366	53	N/A	146	N/A
10/31/2016	4,149	54	N/A	108	N/A
7/31/2016	3,932	55	N/A	71	N/A
4/30/2016	3,697	53	N/A	51	N/A
1/31/2016	3,461	51	N/A	32	N/A
10/31/2015	3,388	50	N/A	35	N/A
7/31/2015	3,315	49	N/A	39	N/A
4/30/2015	3,229	51	N/A	50	N/A
1/31/2015	3,142	53	N/A	61	N/A
10/31/2014	3,077	56	N/A	78	N/A
7/31/2014	3,012	60	N/A	94	N/A
4/30/2014	2,993	57	N/A	87	N/A
1/31/2014	2,973	54	N/A	80	N/A

アナリストによる今後の成長予測

収入対貯蓄率: S5YAは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 1% ) よりも高い成長率であると考えられます。

収益対市場: S5YA今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: S5YA今後 3 年以内に収益を上げることが予想されます。

収益対市場: S5YAの収益 ( 21.5% ) German市場 ( 5.6% ) よりも速いペースで成長すると予測されています。

高い収益成長: S5YAの収益 ( 21.5% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: S5YAの自己資本利益率は、3年後には非常に高くなると予測されています ( 61.6 %)。

Sigma Healthcare 将来の成長

Future 基準チェック /66

主要情報

今後の成長に関する最新情報

Sigma Healthcare Limited Provides Earnings Guidance for the Year 2023

Recent updates

New major risk - Share price stability

New minor risk - Share price stability

First half 2025 earnings released: EPS: AU$0.002 (vs AU$0.011 in 1H 2024)

First half dividend of AU$0.005 announced

Sigma Healthcare Limited to Report Q2, 2025 Results on Sep 25, 2024

Now 22% overvalued

New minor risk - Earnings quality

First half dividend of AU$0.005 announced

Sigma Healthcare Limited to Report Fiscal Year 2024 Results on Mar 21, 2024

New major risk - Shareholder dilution

New minor risk - Shareholder dilution

Sigma Healthcare Limited has filed a Follow-on Equity Offering.

Sigma Healthcare Limited has filed a Follow-on Equity Offering.

Sigma Healthcare Limited, Annual General Meeting, May 30, 2024

Less than half of directors are independent

Sigma Healthcare Limited Announces Christopher Graham Roberts as Director

Sigma Healthcare Limited Declares Fully Franked Dividend for the Six Month Ended July 31, 2023, Payable on October 11, 2023

Sigma Healthcare Limited to Report First Half, 2024 Results on Sep 20, 2023

Sigma Healthcare Limited Appoints Mark Conway as CFO, Effective from 1 November 2023

Sigma Healthcare Limited Announces Executive Changes

Less than half of directors are independent

Full year 2023 earnings released: EPS: AU$0.002 (vs AU$0.007 loss in FY 2022)

Sigma Healthcare Limited Announces Board Changes

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.001 loss in 1H 2022)

Sigma Healthcare Limited Declares Interim Fully Franked Dividend, Payable on 12 October 2022

Sigma Healthcare Limited Announces Executive Changes

Sigma Healthcare Limited Appoints Nigel Simonsz as Chief Financial Officer, Effective 29 August 2022

Sigma Healthcare Limited Appoints Nigel Simonsz as Chief Financial Officer, Effective 29 August 2022

Sigma Healthcare Limited Announces Appointment of Josephine De Martino as Interim Chief Financial Officer

Sigma Healthcare Limited, Annual General Meeting, May 10, 2023

Full year 2022 earnings released: AU$0.007 loss per share (vs AU$0.044 profit in FY 2021)

Sigma Healthcare Limited Provides Earnings Guidance for the Year 2023

Simon Mawhinney Opposes Sigma Healthcare’s Bid to Australian Pharmaceutical

First half 2022 earnings released: AU$0.001 loss per share (vs AU$0.004 loss in 1H 2021)

Independent Non-Executive Director has left the company

Upcoming dividend of AU$0.01 per share

Full year 2021 earnings released: EPS AU$0.061 (vs AU$0.013 loss in FY 2020)

New 90-day high: €0.44

New 90-day high: €0.41

New 90-day high: €0.38

New 90-day high: €0.37

New 90-day high: €0.37

CEO, MD & Executive Director recently bought €82k worth of stock

New 90-day low: €0.33

Sigma Healthcare Appoints Jackie Pearson as Chief Financial Officer

CEO, MD & Executive Director recently bought €180k worth of stock

New 90-day low: €0.35

First half earnings released

Sigma Healthcare Limited Announces No Interim Dividend for the Half Year Ended 31 July 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘